Comparing Lo Loestrin Fe vs Slynd
| Lo Loestrin Fe Remove Lo Loestrin Fe from your drug comparison | Slynd Remove Slynd from your drug comparison |
|
|---|
| Lo Loestrin Fe ethinyl estradiol / norethindrone Remove Lo Loestrin Fe from your drug comparison | Slynd drospirenone Remove Slynd from your drug comparison |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Birth Control. Lo Loestrin Fe may also be used for purposes not listed in this medication guide. |
Prescribed for Birth Control. Slynd may also be used for purposes not listed in this medication guide. |
||||||||
|
Prescription only |
Prescription only |
||||||||
Ratings & Reviews |
|||||||||
Drug Class |
|||||||||
Side Effects |
|||||||||
|
See the full Lo Loestrin Fe side effects document. |
See the full Slynd side effects document. |
||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||
View all Lo Loestrin Fe prices and generic prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Generic Availability |
|||||||||
|
No |
|||||||||
Dosage Form(s) Available |
|||||||||
|
N/A | ||||||||
Brand Names |
|||||||||
| Other ethinyl estradiol / norethindrone brands include: Alyacen 1/35, Alyacen 7/7/7, Aranelle, Aurovela 1.5/30, Aurovela 1/20, Aurovela 24 Fe, Aurovela Fe 1.5/30, Aurovela Fe 1/20, Balziva, Blisovi 24 Fe, Blisovi Fe 1.5/30, Blisovi Fe 1/20, Brevicon, Briellyn, Chabelina Fe, Charlotte 24 Fe, Cyclafem 0.5/35, Cyclafem 1/35, Cyclafem 7/7/7, Cyonanz, Dasetta, Dasetta 1/35, Dasetta 7/7/7, Estrostep Fe, Femcon Fe, femhrt, Finzala, Fyavolv, Gemmily, Generess Fe, Gildagia, Gildess 1.5/30, Gildess 1/20, Gildess 24 Fe, Gildess Fe 1.5/30, Gildess Fe 1/20, Hailey 1.5/30, Hailey 24 Fe, Hailey Fe 1.5/30, Hailey Fe 1/20, Jinteli, Junel 1.5/30, Junel 1/20, Junel Fe 1.5/30, Junel Fe 1/20, Junel Fe 24, Kaitlib Fe, Larin 1.5/30, Larin 1/20, Larin 24 Fe, Larin Fe 1.5/30, Larin Fe 1/20, Layolis Fe, Leena, Leribane, Loestrin 21 1.5/30, Loestrin 21 1/20, Loestrin 24 Fe, Loestrin Fe 1.5/30, Loestrin Fe 1/20, Lomedia 24 Fe, Melodetta 24 Fe, Merzee, Mibelas 24 Fe, Microgestin 1.5/30, Microgestin 1/20, Microgestin Fe 1.5/30, Microgestin Fe 1/20, Minastrin 24 Fe, Necon 0.5/35, Necon 7/7/7, Nexesta Fe, Norinyl 1+35, Nortrel 0.5/35, Nortrel 1/35, Nortrel 7/7/7, Nylia 1/35, Nylia 7/7/7, Ortho-Novum 7/7/7, Philith, Pirmella 1/35, Pirmella 7/7/7, Tarina 24 Fe, Tarina Fe 1/20, Taysofy, Taytulla, Tilia Fe, Tri-Legest, Tri-Legest Fe, Vyfemla, Wera, Wymzya Fe, Zenchent, Zenchent Fe View more |
N/A |
||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||
|
14 hours |
32.5 hours |
||||||||
CSA Schedule**View glossary of terms. |
|||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category |
|||||||||
|
Category X
Not for use in pregnancy
See the full Pregnancy Warnings document. |
Summary unavailable. See the full Pregnancy Warnings document. |
||||||||
Drug Interactions |
|||||||||
|
A total of 425 drugs are known to interact with Lo Loestrin Fe:
|
A total of 275 drugs are known to interact with Slynd:
|
||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions |
|||||||||
|
|||||||||
First Approval Date |
|||||||||
|
October 21, 2010 |
May 23, 2019 |
||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||
|
N/A |
N/A |
||||||||
More Information |
|||||||||
Patient resources |
|||||||||
Professional Resources |
|||||||||
Related Treatment Guide |
|||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.